EuroSIDA is a prospective observational cohort
study of more than 16,000 adult patients under care and follow-up
in a network of 103 hospitals in 33 European countries plus Israel
Data are collected directly from clinics on
individuals using comprehensive standardised clinical record forms.
This allows the flexibility to address novel questions over time
where new issues arise, and the ability to rapidly collect data to
address these from clinics.
Blood samples are also taken and the EuroSIDA
plasma repository currently contains approximately 70,000
specimens. The extensive network forms an impressive surveillance
mechanism across the European continent and allows the
characterisation of the epidemic in different geographical
locations with diverse patient populations and differing access to
The network centres on fostering excellence in
research, sharing expertise and know-how, and providing answers to
key clinically-relevant questions in HIV infection.
The aims of EuroSIDA can be broadly classified
as: examining the efficacy of therapy and the factors that limit
this, detecting current and emerging late onset adverse events
among patients on cART, continuing the surveillance of HIV in
clinics across Europe to describe temporal changes and regional
differences in parameters of overall health status.
information, visit the EuroSIDA website